DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meruvax II (Rubella Virus Vaccine Live) - Current Clinical Trials

 
 



Meruvax II Related Clinical Trials

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [No longer recruiting]

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Completed]

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Completed]

Coadministration of Measles-rubella and Rotavirus Vaccines [Recruiting]

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine [No longer recruiting]

Evaluation of a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox. [Active, not recruiting]

Long-Term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [Completed]

ProQuad® Intramuscular vs Subcutaneous [Recruiting]

Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella, and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month Old Children [Active, not recruiting]

Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella [Oka/Merck] Virus Vaccine Live Safety Study [Completed]

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. [Completed]

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Measles/Mumps/Rubella Vaccine & a Varicella (Chickenpox) Vaccine in Healthy Children [Active, not recruiting]

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine [Recruiting]

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines [Terminated]

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [Completed]

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers [Recruiting]

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis [Recruiting]

Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 – 24 Months [Completed]

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers [Recruiting]

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children [Completed]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age [Recruiting]

Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorixâ„¢ Given With Varilrixâ„¢ [Active, not recruiting]

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group [Active, not recruiting]

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs [Active, not recruiting]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life [Recruiting]

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix�) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R�II), in Children 12 to 15 Months of Age [Recruiting]

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age [Active, not recruiting]

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age [Active, not recruiting]

A Measles, Mumps, and Rubella Investigational Vaccine Trial [Completed]

Immune Responses to Two Dose Varivax +/- MMR-II [Terminated]

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine [Recruiting]

Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorixâ„¢ Given With Varilrixâ„¢ [Completed]

Ontogeny of Measles Immunity in Infants [Recruiting]

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV [Completed]

Rubella Susceptibility in Multiparous Women [Active, not recruiting]

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs [Active, not recruiting]

Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) [Not yet recruiting]

MMR and Varicella Vaccine in Premature Infants [Completed]

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines [Active, not recruiting]

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals’Hib-MenC Given With Priorix™ in Toddlers (13–14 m) Primed With 3 Doses of Hib and MenC-CRM197 [Completed]

Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012